CLASS II ONGOING Device recall · Reported 6 Jan 2021 · FDA Enforcement Report

Roche cobas pro integrated solutions (cobas pro ISE recalled

Roche Diagnostics Operations is recalling Roche cobas pro integrated solutions (cobas pro ISE, cobas c 503, and cobas e 801, distributed nationwide in the US. The recall was initiated on 8 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial Numbers: 1925-10; 1931-04; 1931-05;1931-07;1937-10; 1938-01; 1942-10
Quantity recalled7 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0755-2021
FDA event ID
86981
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Ongoing
Recall initiated
8 Dec 2020
FDA classified
30 Dec 2020
Reported
6 Jan 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 Dec 2020Recall initiated by company
30 Dec 2020Classified by FDA+22 days
6 Jan 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for Changed Configuration Settings on the cobas 8000 modular analyzer series/cobas pro integrated solutions, may cause incorrect results in several affected parameters. In the case of poor sample quality, discrepant results may remain undetected due to the absence of associated data flags.

Product as listed by the FDA

Roche cobas pro integrated solutions (cobas pro ISE, cobas c 503, and cobas e 801 analytical units) Chemistry Analyzer (photometric discrete), for clinical use Part Number: 05641446001

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Is Roche cobas pro integrated solutions (cobas pro ISE, cobas c 503, and cobas e 801 recalled?

Yes. Roche Diagnostics Operations recalled Roche cobas pro integrated solutions (cobas pro ISE, cobas c 503, and cobas e 801 on 8 Dec 2020. The recall is Class II and its status is Ongoing. Recall number Z-0755-2021.

Why was it recalled?

Potential for Changed Configuration Settings on the cobas 8000 modular analyzer series/cobas pro integrated solutions, may cause incorrect results in several affected parameters. In the case of poor sample quality, discrepant results may remain undetected due to the absence of associated data flags.

Which lots are affected?

Serial Numbers: 1925-10; 1931-04; 1931-05;1931-07;1937-10; 1938-01; 1942-10

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Test Kits & Diagnostics recalls

All 2,656